EVFM

Evofem Biosciences, Inc. Common Stock
EVFM

Overview Fund Activity
Delisted

EVFM was delisted on the 10th of August, 2022.

Back to rankings

68 hedge funds and large institutions have $9.84M invested in Evofem Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+6
Holders Change %
+9.68%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
17
Closed
5
Calls
$714K
Puts
$143K
Net Calls
+$571K
Net Calls Change
-$107K

Top Buyers

1
MCP
1
Mirador Capital Partners
California
$955K
2
Citadel Advisors
2
Citadel Advisors
Florida
$105K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$517K
4
Morgan Stanley
4
Morgan Stanley
New York
$88K
5
TAM
5
Tocqueville Asset Management
New York
$17K

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$167K
3
GCP
3
GSA Capital Partners
United Kingdom
$0
4
Osaic Holdings
4
Osaic Holdings
Arizona
$3.07M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$230K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
51
Bank of America
North Carolina
$1K +$835 +132 +508%
Citigroup
52
Citigroup
New York
$1K +$1K +167 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$767 +$5 +1 +0.7%
LTI
54
Laffer Tengler Investments
Tennessee
$78 – – –
BBA
55
Baker Bros. Advisors
New York
– -$1.01M -179,807 Closed
GCP
56
GSA Capital Partners
United Kingdom
– -$347K -61,652 Closed
VF
57
Virtu Financial
New York
– -$98K -17,338 Closed
SWM
58
Spire Wealth Management
Virginia
– -$5K -867 Closed
1 2
3